TRICHODYSPLASIA SPINULOSA

This adverse event was reported 381 times

These drugs are most commonly taken by patients reporting TRICHODYSPLASIA SPINULOSA:

# Drug Count
0 TACROLIMUS 310
1 TACROLIMUS EXTENDED-RELEASE CAPSULES 303
2 TACROLIMUS OINTMENT 0.1% 303
3 MYCOPHENOLATE MOFETIL 242
4 PREDNISONE 196
5 MYCOPHENOLIC ACID 50
6 METHYLPREDNISOLONE 41
7 MYCOPHENILIC ACID 41
8 PREDNISOLONE 32
9 PREDNISOLONE ORAL 32
See all common drugs associated with TRICHODYSPLASIA SPINULOSA

TRICHODYSPLASIA SPINULOSA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CIDOFOVIR ANHYDROUS 9 0.0062
1 TACROLIMUS OINTMENT 0.1% 303 0.0024
2 TACROLIMUS EXTENDED-RELEASE CAPSULES 303 0.0024
3 TACROLIMUS 310 0.0019
4 MYCOPHENILIC ACID 41 0.0019
5 MYCOPHENOLATE MOFETIL 242 0.0017
6 MARAVIROC 4 0.0017
7 ANTI-THYMOCYTE GLOBULIN (RABBIT) 13 0.0016
8 MYCOPHENOLIC ACID 50 0.0015
9 SIROLIMUS 19 0.0014
See all drugs enriched for association with TRICHODYSPLASIA SPINULOSA